Not applicableEnded earlyNCT01303237
What this trial is testing
A Post Marketing Surveillance Study to Assess the Safety and Efficacy of Cetuximab Plus Radiotherapy in Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Who this might be right for
Unresectable Locally Advanced Squamous Cell Carcinoma of Head and NeckLA SCCHN
Merck KGaA, Darmstadt, Germany 88